(Q40098147)

17 September 2017

title

Studies on xenogenic antisera to tumor-associated antigen of ovarian carcinoma (English)

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198173

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

author name string

M. A. Gerber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198173

29 December 2022

I. Faiferman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198173

29 December 2022

C. J. Cohen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198173

29 December 2022

D. Koffler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198173

29 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=198173

29 December 2022

publication date

1 September 1977

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0090122977901076?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

https://api.elsevier.com/content/article/PII:0090122977901076?httpAccept=text/plain

29 December 2022

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Clinical Immunology and Immunopathology

29 December 2022

published in

1 reference

17 September 2017

volume

8

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

171-180

1 reference

Cell-mediated immunity in patients with ovarian carcinoma.

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions

29 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Immunologic studies of human serous cystadenocarcinoma of ovary.Demonstration of tumor-associated antigens

29 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Common antigenic component in ovarian carcinomas: demonstration by double diffusion and immunofluorescence techniques.

29 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease

29 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Biochimica et Biophysica Acta

29 December 2022

6

417

123

Fuks

1974

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Subcellular Separation and Molecular Nature of Human Histocompatibility Antigens (HL-A)

29 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Inhibition of human leukocyte migration in agarose by KCl extracts of carcinoma of the lung

29 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma

29 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.

29 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Demonstration of tumor-associated antigens in human gynecologic malignancies

29 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Antigenicity of ovarian and cervical malignancies with a view toward possible immunodiagnosis

29 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Ovarian tumor-specific antigens

29 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Characterization of tumor-associated antigens of ovarian carcinoma

29 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Immunological relationship of the carcinoembryonic antigen and the fetal sulfoglycoprotein antigen.

29 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein

29 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Immunological studies of membrane glycoproteins isolated from human breast carcinomas

29 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

24

34

2125

Newman

1974

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein

29 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Association of an Isomeric Species of Carcinoembryonic Antigen with Neoplasia of the Gastrointestinal Tract

29 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

27

29

1535

McNeil

1969

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Intestinal Antigenicity of Ovarian Mucinous Cystadenomas

29 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract

29 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

Carcinoembryonic antigen in patients with gynecologic malignancy

29 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

31

35

1433

van Nagell

1975

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

32

35

3807

Marchand

1975

1 reference

https://api.crossref.org/works/10.1016/0090-1229(77)90107-6

29 December 2022

Identifiers

1 reference

17 September 2017

1 reference